BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, June 19, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Oct. 19, 2020

Oct. 19, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3M, Abbott, Apollo Medco, Beahm Designs, BD, Beroni Group, Caredx, Eko, Genscript Biotech, Labcorp, Machine Solutions, Medovate, Plexision, Quidel, Vygon.
Read More

Other news to note for Oct. 19, 2020

Oct. 19, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Akron, Aridis, Beyond Air, Bioeleven, Brainstorm, Biospecifics, Cardinal, Catalyst, Cocrystal, Cognition, Connectyx, Endo, Evotec, Genentech, Genesis, Huadong, Immunogen, Just-Evotec, Kamada, Kazia, Koligo, NGM, Oncomyx, Orgenesis, Tissue Genesis, Samsung, Sanofi, Sesen, Som, Sunshine, Synairgen, Transcelerate, Translate.
Read More

Other news to note for Oct. 16, 2020

Oct. 16, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Altrix Medical, Chembio Diagnostics, Eurofins Biomnis, Jud Care, Luxfer, Myriad Genetics, Neurox, Nexgel, Stratus, Transforming Systems, Ursa Health, Vitalhub.
Read More

Other news to note for Oct. 16, 2020

Oct. 16, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Anges, Aslan, Beyond Air, Er-kim, ICER, Macrogenics, Omeros, Takeda.
Read More

Other news to note for Oct. 15, 2020

Oct. 15, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Added Value Business and Marketing Solutions, Boehringer Ingelheim, Bioaffinity, Biovo Technologies, Blackstone Medical Services, Cardiac Safety Research Consortium, Fujifilm Medical Systems U.S.A., IDbyDNA , Illumina, IT-IS International, Jaya Unggul Gemilang, Konica Minolta, Mevion, Novacyt, Nupaf, Olim Het, Philips, Precision Pathology Services, Scriptsender, Smiths Medical, Summit, Trekstor, Victory Square, Volpara Solutions.
Read More

Other news to note for Oct. 15, 2020

Oct. 15, 2020

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allogene, Amag, Antlia, Apellis, Astellas, Covis, Entos, FS, Gemini, Insilico, Iota, Mallinckrodt, Meabco, Mirum, Oncopep, Mana, National Comprehensive Cancer Network, Puma, Sanofi, Science 37, Surrozen, Taisho, Tenax, Titan, Tonix, Translate, XL-protein.


Read More

Cyclerion provides updates on their development of olinciguat and IW-6463

Oct. 15, 2020

Other news to note for Oct. 14, 2020

Oct. 14, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: AMPS, Biolife Solutions, Centogene, Ers Genomics, Exact Sciences, Fasmac, Glyconics, Hancock Jaffee, Helius Medical Technologies, HP, Merit Medical Systems, Opgen, Opsens, Paragon Genomics, Periandx, Pillar Biosciences, Sengenics, Summa Equity, Surlogs, U-Diagnostics, Veeva, Veo Diagnostics, Vivalnk, Wheeler Labs.
Read More

Other news to note for Oct. 14, 2020

Oct. 14, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arvinas, Bioclonetics, Blue Oak, Boehringer, Denali, Dendreon, Emmaus, Enzolytics, Exscientia, Gilead, Immunomedics, Kadmon, Lactiga, Mediwound, Moberg, Novan, Oxford, Passage, Polyphor, Qihan, Redhill, Rezolute, Secarna, Vaxart, Xoma.
Read More

Other news to note for Oct. 13, 2020

Oct. 13, 2020
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Aim Immunotech, Akari, Altimmune, Ampio, Anpac Bio-Medical Science, Antengene, ATCC, Auravax, Beigene, Betterlife, Bintai Kinden, Bioatla, Biogen, Biontech, Bostongene, Citius, Complix, Corneagen, Cstone, Curon, Denali, Eisai, Eli Lilly, GT, Hitgen, ILC, IMV, Innovent, Invetech, Johnson & Johnson, Kaleido, Kemwell, Kindred, Laboratoires Théa, Ligand, Mapi, Molecular Partners, Moleculin, NEC, Novellus, Nugenerex Immuno-Oncology, Oblique, Ocugen, Olix, Oncimmune, Orbis International, Oxford Biomedica, Pfizer, Renibus, Rentschler, Rhizen, Santen, Shenzhen Hepalink, Sorrento, Spartina, Sumitomo Chemical, Sumitomo Dainippon, Sunovion, Sunshine, Transgene, Treefrog, Urovant Sciences, Vaxart, Vir, Virtrial, Wuxi.
Read More
Previous 1 2 … 333 334 335 336 337 338 339 340 341 … 1400 1401 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing